GlassScriptPhysician profile
Michele Godorecci
NPI 1255402079
$4,125.94
in general payments reported to CMS, 2019-2025
33 companies · $501 in 2025
The $501 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $162 · 2021: $455 · 2022: $734 · 2023: $855 · 2024: $821 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,078 · Education: $99.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,078.08 |
| Education | $99.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $491.52 | 2019-2025 | |
| Astellas Pharma US INC | $432.12 | 2021-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $384.82 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $338.13 | 2023-2025 | Myfembree, Gemtesa |
| Amgen INC. | $296.18 | 2021-2025 | Evenity, Prolia, Prolia |
| Mayne Pharma Commercial LLC | $294.68 | 2021-2025 | |
| Hologic Sales and Service, LLC | $241.21 | 2019-2024 | Acessa Provu System, Coolseal Generator, Novasure |
| Exeltis, USA INC. | $139.35 | 2019-2025 | Slynd |
| Amag Pharmaceuticals, INC. | $126.50 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.12 | 2019-2025 | |
| Therapeuticsmd, INC. | $108.18 | 2019-2022 | |
| Agile Therapeutics, INC. | $95.74 | 2021-2022 | |
| Myovant Sciences INC. | $94.85 | 2022 | |
| Evofem Biosciences, INC. | $90.91 | 2021-2025 | Solosec, Phexx, Phexxi |
| Merck Sharp & Dohme LLC | $87.93 | 2019-2024 | Gardasil 9, Gardasil |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $83.54 | 2023-2025 | Paragard T 380a, Endosee |
| Exact Sciences Corporation | $81.24 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Millicent US INC | $79.05 | 2019-2025 | Intrarosa, Femlyv, Femring |
| Covidien LP | $71.44 | 2019-2020 | |
| Lupin INC. | $71.43 | 2019 | |
| Shield Therapeutics INC | $59.91 | 2025 | |
| Becton, Dickinson and Company | $41.03 | 2019-2021 | |
| Organon LLC | $39.88 | 2021-2023 | Nexplanon |
| Avion Pharmaceuticals | $38.72 | 2019-2021 | |
| Cumberland Pharmaceuticals, INC. | $35.72 | 2021-2022 | |
| Allergan, INC. | $35.21 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $27.56 | 2019 | |
| Mylan Pharmaceuticals INC. | $25.66 | 2022 | |
| Bard Access Systems, INC. | $24.15 | 2019 | |
| Medicem INC. | $20.71 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $16.34 | 2025 | |
| Sage Therapeutics, LLC | $15.21 | 2025 | Zurzuvae |
| Ferring Pharmaceuticals INC. | $13.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Godorecci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.